HLA allele variation as a potential explanation for the geographical distribution of granulomatosis with polyangiitis

Rheumatology (United Kingdom)

Volumn 54, Issue 2, 2015, Pages 359-362

  Watts, Richard A ^a,b,d   MacGregor, Alex J ^b   Mackie, Sarah L ^c  

^a IPSWICH HOSPITAL NHS TRUST   (United Kingdom)

^b UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^c UNIVERSITY OF LEEDS   (United Kingdom)

^d IPSWICH HOSPITAL   (United Kingdom)

Author keywords

Epidemiology; Genetics; Granulomatosis with polyangiitis; HLA; Vasculitis

Indexed keywords

HLA DPB1 ANTIGEN; HLA DP ANTIGEN; HLA-DPB1 ANTIGEN;

ALLELE; ARTICLE; DISEASE CARRIER; FREQUENCY ANALYSIS; GENE; GENE FREQUENCY; GENETIC VARIATION; GEOGRAPHIC DISTRIBUTION; HLA SYSTEM; HUMAN; LINEAR REGRESSION ANALYSIS; MORBIDITY; MULTIVARIATE ANALYSIS; PIZ GENE; POPULATION; PRIORITY JOURNAL; WEGENER GRANULOMATOSIS; GENETIC PREDISPOSITION; GENETICS; GRANULOMATOSIS WITH POLYANGIITIS; HEALTH; INCIDENCE; MEDICAL GEOGRAPHY;

GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GEOGRAPHY, MEDICAL; GLOBAL HEALTH; GRANULOMATOSIS WITH POLYANGIITIS; HLA-DP BETA-CHAINS; HUMANS; INCIDENCE; MULTIVARIATE ANALYSIS;

EID: 85005773780     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/keu321     Document Type: Article

References (18)

1. Watts RA, Scott DG. ANCA vasculitis over the world What do we learn from country differences? Presse Med 2013; 42(4 Pt 2):591–3.
2. Mahr A, Guillevin L, Poissonnet M, Aymé S. Prevalences of polyarteritis nodosa, microscopic polyangiitis, Wegener's granulomatosis, and Churg-Strauss syndrome in a French urban multiethnic population in 2000: a capture-recapture estimate. Arthritis Rheum 2004;51:92–9.
3. Gibson A, Stamp LK, Chapman PT, O'Donnell JL. The epidemiology of Wegener's granulomatosis and microscopic polyangiitis in a Southern Hemisphere region. Rheumatology 2006;45:624–8.
4. Cao Y, Schmitz JL, Yang J et al. DRB1*15 allele is a risk factor for PR3-ANCA disease in African Americans. J Am Soc Nephrol 2011;22:1161–7.
5. Fujimoto S, Watts RA, Kobayashi S et al. Comparison of the epidemiology of anti-neutrophil cytoplasmic antibody-associated vasculitis between Japan and the U.K. Rheumatology 2011;50:1916–20.
6. Watts RA, Lane SE, Scott DG et al. Epidemiology of vasculitis in Europe. Ann Rheum Dis 2001;60:1156–7.
7. Gatenby PA, Lucas RM, Engelsen O, Ponsonby A-L, Clements M. Antineutrophil cytoplasmic antibody-associated vasculitides: could geographic patterns be explained by ambient ultraviolet radiation? Arthritis Rheum 2009;61:1417–24.
8. Heckmann M, Holle JU, Arning L et al. The Wegener's granulomatosis quantitative trait locus on chromosome 6p21.3 as characterised by tagSNP genotyping. Ann Rheum Dis 2008;67:972–9.
9. Jagiello P, Aries P, Arning L et al. The PTPN22 620W allele is a risk factor for Wegener's granulomatosis. Arthritis Rheum 2005;52:4039–43.
10. 1 antitrypsin and its polymers. Ann Rheum Dis 2011;70:1851–6.
11. Luo H, Chen M, Yang R, Xu P-C, Zhao M-H. The association of HLA-DRB1 alleles with antineutrophil cytoplasmic antibody-associated systemic vasculitis in Chinese patients. Hum Immunol 2011;72:422–5.
12. Lyons PA, Rayner TF, Trivedi S et al. Genetically distinct subsets within ANCA-associated vasculitis. N Engl J Med 2012;367:214–23.
13. De Serres FJ, Blanco I. Prevalence of a1-antitrypsin deficiency alleles PI*S and PI*Z worldwide and effective screening for each of the five phenotypic classes PI*MS, PI*MZ, PI*SS, PI*SZ, and PI*ZZ: a comprehensive review. Ther Adv Respir Dis 2012;6:277–95.
14. Mohammad A, Segelmark M. Primary systemic vasculitis with severe a1-antitrypsin deficiency revisited. Scand J Rheumatol 2014;43:242–5.
15. Gonzalez-Galarza FF, Christmas S, Middleton D, Jones AR. Allele frequency net: a database and online repository for immune gene frequencies in worldwide populations. Nucleic Acids Res 2011;39: D913–9.
16. Leavitt RY, Fauci AS, Bloch DA et al. The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum 1990; 33:1101–7.
17. Watts R, Lane S, Hanslik T et al. Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies. Ann Rheum Dis 2007; 66:222–7.
18. Jennette JC, Falk RJ, Andrassy K et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 1994;37: 187–92.